USPTO trademark

LUPROLINK

RegisteredUSPTOWord markClass 9Class 35Class 42

"LUPROLINK" is a word mark owned by Abbvie Endocrine Inc., filed at the USPTO on January 16, 2008. It is registered and covers classes 9, 35 and 42.

View Abbvie Endocrine Inc. portfolio Get this data via the API

Data current as of July 1, 2026Official USPTO record

As filed with the USPTO

Status: Registered; Since July 9, 2018
Filed: January 16, 2008
Registered: August 5, 2008
Expires: Not recorded
Application no.: 77372724
Registration no.: 3480499
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 3 classes

Ownership

Who owns LUPROLINK

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Abbvie Endocrine Inc.

ABBV · North Chicago, United States

12 trademarks in the portfolioView company

Representative

Maryam S. Arastu

AbbVie Inc.

Goods and services

What the mark covers

The products and services LUPROLINK is filed for, grouped by Nice class.

09Class 9 · Computers and Scientific Devices
RFID readers; Computer software for tracking and authenticating pharmaceutical products and inventory management
35Class 35 · Advertising and Business
Inventory management in the field of pharmaceutical products
42Class 42 · Computer and Scientific Services
Providing on-line non-downloadable software for tracking and authenticating pharmaceutical products and inventory management

History

What has happened so far

Steps recorded by the USPTO, newest first.

June 30, 2026Teas withdrawal of attorney received-firm retains
June 30, 2026Teas change of correspondence received
June 30, 2026Attorney/dom.rep.revoked and/or appointed
June 30, 2026Teas revoke/app/change addr of atty/dom rep received
July 9, 2018Notice of acceptance of sec. 8 & 9 - e-mailed
July 9, 2018Registered and renewed (first renewal - 10 yrs)
July 9, 2018Registered - sec. 8 (10-yr) accepted/sec. 9 granted
July 9, 2018Case assigned to post registration paralegal
June 26, 2018Teas section 8 & 9 received
August 5, 2017Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed

10 earlier steps on the official record.

FAQ

About LUPROLINK

Who owns the trademark "LUPROLINK"?

The USPTO trademark "LUPROLINK" (application 77372724) is owned by Abbvie Endocrine Inc.

What is the status of "LUPROLINK"?

Its status at the USPTO is: registered.

When was "LUPROLINK" registered?

It was registered on August 5, 2008.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LUPROLINK and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d210f-a19e-7596-9ec5-a39879afcba6
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d210f-a19e-7596-9ec5-a39879afcba6",
  "object": "trademark",
  "mark_text": "LUPROLINK",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "77372724",
  "filing_date": "2008-01-16",
  "nice_classes": [
    9,
    35,
    42
  ],
  "owners": [
    {
      "name": "ABBVIE ENDOCRINE INC.",
      "entity_id": "ent_019eb6fa-94c4-719f-bb29-d46f57286d87"
    }
  ]
}